Stocktoria
EBOS Group Limited EBO.NZ
NZ · New Zealand Exchange · XNZE · stock · Healthcare · website
EBOS Group Limited financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | A$13.2B | A$14.4B | A$13.3B | A$11.9B |
| Gross profit | A$1.8B | A$1.8B | A$1.7B | A$1.4B |
| SG&A expense | A$632.7M | A$619.4M | A$578.3M | A$467.1M |
| Operating income | A$455.6M | A$527.2M | A$499.0M | A$395.5M |
| Interest expense | A$96.3M | A$91.0M | A$73.8M | A$25.4M |
| Income tax | A$93.1M | A$120.2M | A$119.7M | A$103.4M |
| Net income | A$231.7M | A$296.7M | A$275.7M | A$224.6M |
| EPS (diluted) | A$1.17 | A$1.54 | A$1.45 | A$1.27 |
| Cash & equivalents | A$198.4M | A$237.0M | A$230.6M | A$573.6M |
| Inventory | A$1.4B | A$1.3B | A$1.3B | A$1.2B |
| Total assets | A$7.8B | A$7.4B | A$7.0B | A$6.9B |
| Total liabilities | A$4.9B | A$4.7B | A$4.5B | A$4.6B |
| Shareholders' equity | A$2.9B | A$2.7B | A$2.6B | A$2.5B |
Growth · year-over-year · Revenue CAGR 3.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | -8.3% | +8.2% | +11.9% | — |
| Net income growth | -21.9% | +7.6% | +22.7% | — |
| EPS growth | -24.0% | +6.7% | +13.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · NZ · as of 2025-06-30. Figures in AUD; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.